Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium

被引：10

作者：

Piccini, Jonathan P. ^{[1
,2
]}

Clark, Richard L. ^{[3
]}

Kowey, Peter R. ^{[4
,5
]}

Mittal, Suneet ^{[6
]}

Dunnmon, Preston ^{[7
]}

Stockbridge, Norman ^{[7
]}

Reiffel, James A. ^{[8
]}

Turakhia, Mintu P. ^{[9
,10
]}

Ziegler, Paul D. ^{[3
]}

Kleiman, Robert B. ^{[11
]}

Ismat, Fraz ^{[12
]}

Sager, Philip ^{[13
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC 27708 USA

[2] Duke Clin Res Inst, Durham, NC 27705 USA

[3] Mechron Diagnost & Monitoring Res, Mounds View, MN USA

[4] Lankenau Heart Inst, Philadelphia, PA USA

[5] Jefferson Med Coll, Philadelphia, PA USA

[6] Valley Hlth Syst, Ridgewood, NJ USA

[7] US FDA, Div Cardiovasc & Renal Prod, Rockville, MD 20857 USA

[8] Columbia Univ, Div Cardiol, Med Ctr, New York, NY USA

[9] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA

[10] Stanford Univ, Palo Alto, CA 94304 USA

[11] eRes Technol Inc ERT, Philadelphia, PA USA

[12] Bristol Myers Squibb, Princeton, NJ USA

[13] Stanford Univ, Stanford, CA 94305 USA

来源：

AMERICAN HEART JOURNAL | 2017年 / 187卷

关键词：

ATRIAL-FIBRILLATION; PROARRHYTHMIC RISK; HEPATITIS-C; SOFOSBUVIR; ARRHYTHMIAS; AMIODARONE; DEVICES; FOCUS;

D O I：

10.1016/j.ahj.2017.01.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This white paper, prepared by members of the Cardiac Safety Research Consortium (CSRC), discusses important issues regarding scientific and clinical aspects of long-term electrocardiographic safety monitoring during clinical drug development. To promote multistakeholder discussion of this topic, a Cardiac Safety Research Consortium sponsored Think Tank was held on 2 December 2015 at the American College of Cardiology's Heart House in Washington, DC. The goal of the Think Tank was to explore how and under what circumstances new and evolving ambulatory monitoring technologies could be used to improve and streamline drug development. This paper provides a detailed summary of discussions at the Think Tank: it does not represent regulatory guidance.

引用

页码：156 / 169

页数：14

共 50 条

[41] Long-Term Safety of Tocilizumab from Large Clinical Trial and Postmarketing Populations
Mohan, Shalini
Michalska, Margaret
Yourish, Jeffrey
Pei, Jinglan
Gale, Sara
Birchwood, Christine
Berber, Erhan
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[42] LONG-TERM SAFETY OF TOCILIZUMAB FROM LARGE CLINICAL TRIAL AND POSTMARKETING POPULATIONS
Mohan, S.
Michalska, M.
Yourish, J.
Pei, J.
Gale, S.
Birchwood, C.
Berber, E.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 95 - 95
[43] CARDIAC SAFETY AND CLINICAL EFFICACY OF HIGH DOSE DOMPERIDONE FOR LONG-TERM TREATMENT OF GASTROPARESIS SYMPTOMS
Woods, Kevin
Espino, Karina
Sarosiek, Irene
Waterhouse, Nathan
Siddiqui, Tariq
McCallum, Richard W.
GASTROENTEROLOGY, 2020, 158 (06) : S622 - S622
[44] Aripiprazole: Long-term efficacy and safety. Case report
Goldin, V
Rena, K
Boris, R
EUROPEAN PSYCHIATRY, 2004, 19 : 175S - 176S
[45] Interim report of phase 2 long-term safety of belatacept
Vincenti, Flavio
Larsen, Christian
Muehlbacher, Ferdinand
Charpentier, Bernard
TRANSPLANT INTERNATIONAL, 2007, 20 : 74 - 74
[46] BIOMARKER DEVELOPMENT: ITS ROLE IN CLINICAL RESEARCH AND DRUG SAFETY
Farre, M.
Lucena, M. I.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 23 - 23
[47] NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank
Reiffel, James A.
Weitz, Jeffrey I.
Reilly, Paul
Kaminskas, Edvardas
Sarich, Troy
Sager, Philip
Seltzer, Jonathan
AMERICAN HEART JOURNAL, 2016, 177 : 74 - 86
[48] LONG-TERM SAFETY AND CLINICAL EFFICACY OF A TOOTH WHITENING SYSTEM
KOWITZ, GM
NATHOO, SA
WONG, R
CHMIELEWSKI, MB
RUSTOGI, K
JOURNAL OF DENTAL RESEARCH, 1995, 74 : 239 - 239
[49] CLINICAL SAFETY OF LONG-TERM ADMINISTRATION OF GOSSYPOL IN 32 CASES
XU, D
CAI, WJ
ZHU, BH
DONG, CJ
ZHENG, ZC
GAO, ZQ
CONTRACEPTION, 1988, 37 (02) : 129 - 135
[50] Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
Pea, Federico
Viale, Pierluigi
Cojutti, Piergiorgio
Del Pin, Barbara
Zamparini, Eleonora
Furlanut, Mario
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) : 2034 - 2042

← 1 2 3 4 5 →